Effect of Enhanced Glycemic Control with Saxagliptin on Endothelial Nitric Oxide Release and CD40 Levels in Obese RatsRonald P. Mason, Tadeusz Maliñski, Mary Walter et al.|Journal of Atherosclerosis and Thrombosis|2011Cited by 62
Loss of Arterial and Renal Nitric Oxide Bioavailability in Hypertensive Rats With Diabetes: Effect of -BlockersR. Preston Mason, Tadeusz Maliñski, Ruslan Kubant et al.|American Journal of Hypertension|2009Cited by 31
DRONEDARONE ENHANCES RAT AORTIC AND GLOMERULAR ENDOTHELIAL NITRIC OXIDE RELEASE IN A DOSE-DEPENDENT MANNERP.L. Mason, Tadeusz Maliñski, Robert F. Jacob et al.|Journal of the American College of Cardiology|2011Cited by 3
DIPEPTIDYL PEPTIDASE-4 INHIBITOR, SAXAGLIPTIN, ENHANCES NITRIC OXIDE BIOAVAILABILITY IN AORTIC AND RENAL ENDOTHELIUM FROM OBESE, INSULIN-RESISTANT RATSTadeusz Maliñski, Aouatef Bellamine, Yoshiko Mizuno et al.|Journal of the American College of Cardiology|2010Cited by 0